NCT05464745 - Bioequivalence Study of 8 mg Perindopril Tert-butylamine / 2.5 mg Indapamide Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide Film-coated Tablets in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 19, 2021

Primary Completion Date

June 9, 2021

Study Completion Date

June 9, 2021

Conditions

BioequivalenceHealthy Subjects

Interventions

DRUG

PERINDOPRES® DUO 8 mg perindopril tert-butylamine / 2.5 mg indapamide tablets

Oral, generic fixed-dose combination of perindopril tert-butylamine (angiotensin-converting-enzyme inhibitor for the treatment of high blood pressure and heart failure) and indapamide (thiazide-like diuretic used in the treatment of hypertension and decompensated heart failure)

DRUG

Noliterax® 10 mg/2.5 mg 10 mg perindopril arginine / 2.5 mg indapamide film-coated tablets

Oral, innovative fixed-dose combination of perindopril arginine (angiotensin-converting-enzyme inhibitor for the treatment of high blood pressure and heart failure) and indapamide (thiazide-like diuretic used in the treatment of hypertension and decompensated heart failure)

Trial Locations (1)

11196

International Pharmaceutical Research Center, Amman